Compressed Veterinary Bolus Manufacture With Poorly Compactible Sulphur

Direct compression of sulfur sublimatum with mean particle size below 150 µm produces tablets with capping tendency and low tensile strength because sulfur particles undergo brittle fracture at compaction pressures above 120 MPa and exhibit negligible plastic deformation. A wet granulation route using polyvinylpyrrolidone K30 at 3–5% w/w as binder improves compressibility when the granulation endpoint is controlled by impeller torque rather than fixed time. In production-scale high-shear mixers with bowl volumes of 300–600 L, batch-to-batch variance in granule density occurs when raw sulfur bulk density falls outside 0.60–0.75 g/cm³. The inclusion of 5–10% w/w microcrystalline cellulose reduces segregation during tablet press feed frame operation, but over-lubrication with magnesium stearate above 1.0% w/w extends disintegration time beyond 15 min as measured by Ph. Eur. 2.9.1. Tablet hardness is not a sufficient predictor of friability for sulfur-containing matrices; friability testing according to Ph. Eur. 2.9.7 at 25 rpm for 100 revolutions should be paired with visual inspection for edge chipping.

Sulfur is practically insoluble in water, so disintegration and dispersion of the active in the gastrointestinal tract govern availability rather than dissolution rate. In ruminants, a portion of orally administered sulfur may be reduced to hydrogen sulfide by rumen microflora, which can produce neurotoxic effects at high doses; therefore, bolus products for cattle must be formulated with a defined maximum sulfur intake per animal per day, and published data for systemic absorption of elemental sulfur from oral bolus formulations is limited. A lactose-free granulation may be required for animals with lactose intolerance, but replacement with dibasic calcium phosphate dihydrate raises tablet weight and affects compaction force. The ejection force from 19.0 × 9.0 mm oval dies increases when sulfur is lubricated with sodium stearyl fumarate instead of magnesium stearate; this may require tooling with chromium nitride coating to prevent picking.

Scale-up from laboratory V-blenders to 600 L high-shear granulators should not rely on geometric similarity alone because sulfur hydrophobicity produces dead zones on baffles. Cleaning validation limits for sulfur residues in shared facilities can be set using swab sampling and high-performance liquid chromatography with ultraviolet detection after dissolution in carbon disulfide; carbon disulfide handling must comply with local explosive atmosphere directives. The API is combustible as a dust, and mills fitted with 70 °C maximum surface temperature motors should be used. Granule size distribution measured by sieve analysis should meet d10 > 75 µm, d50 150–250 µm, and d90 < 500 µm for consistent die fill.

How Does Electrostatic Surface Charge Constrain Capsule Filling of Sublimed Sulphur?

During semi-automatic capsule filling, sulfur flowers develop triboelectric charge when blended with lactose monohydrate in stainless steel vessels at relative humidity below 35% RH. The charged particles adhere to tamping pins and capsule bushings, producing fill weight variability greater than 5% RSD on intermittent-motion capsule machines. Conditioning the blend at 45–55% RH for 24 h reduces static accumulation but may hydrate hygroscopic excipients. Alternatively, 0.1–0.3% w/w colloidal silicon dioxide improves flow and charge dissipation, provided it is incorporated before final blending. For hard gelatin capsules containing sulfur at 50 mg or 100 mg per unit, the powder bed volume must be adjusted to the tapped density of the blend, which typically changes by 10–15% after vibration. Capsule disintegration testing under Ph. Eur. 2.9.1 is performed with discs only when the formulation contains sustained-release components; conventional sulfur-lubricant blends can pass without discs.

Dust explosion hazards are a production-scale concern because sulfur dust has a minimum ignition energy below 10 mJ; NFPA 655 requires inerting or explosion venting for size reduction and transfer operations. Capsule filling machines should be equipped with conductive wheels and grounded discharge chutes to limit surface charge. In-process checks on fill weight are required every 30 min on machines operating above 6,000 capsules/h, because static variation can shift powder bed density without visible hopper bridging. Excipient selection for capsules differs from tablets because the force applied during plug formation is lower; brittle sulfur particles may not fragment, so the capsule plug can retain a high void fraction. This void fraction can be reduced by adding 10–20% w/w microcrystalline cellulose with a tapped density above 0.65 g/cm³. The final blend should have a Hausner ratio below 1.25 and a Carr index below 20% to ensure consistent capsule fill.

Veterinary dusting powders containing sulfur sublimatum are compounded as nonsterile preparations under conditions aligned with USP <795> and are applied to superficial equine and bovine dermatological lesions. The active particle size is critical for both adherence and ectoparasite contact; a sieve fraction with d90 ≤ 75 µm is preferred because larger particles dislodge from hair shafts within 6–12 h of animal movement. Blending with zinc oxide at 10–20% w/w and talc at 30–50% w/w prevents agglomeration in high-humidity barn environments, but zinc oxide absorbs moisture above 75% RH and may form hard agglomerates that block a rotary powder sifter. Heavy metal limits for sulfur used in cutaneous veterinary formulations are specified in relevant pharmacopoeial monographs, and analytical confirmation by inductively coupled plasma mass spectrometry after microwave digestion is accepted when the limit test is not sufficiently sensitive. Sulfur reacts with copper and copper alloys in storage bins; equipment contact surfaces should be stainless steel 316L or epoxy-lined steel. The keratolytic effect is concentration-dependent, and compounded preparations for food-producing animals require assignment of withdrawal periods based on tissue residue data where available; published data for sulfur residues after topical use is limited.

Process control for dusting powders includes sieve retention, moisture content, and microbial limits. Sulfur sublimatum for cutaneous use is expected to comply with the pharmacopoeial limit for sulfated ash as determined by Ph. Eur. 2.4.14, and residual sulfite is controlled because sulfur exposed to air may form sulfur dioxide at elevated temperatures. The milling operation should use a pin mill with nitrogen purge if the target particle size is below 30 µm, since fine sulfur dust above the lower explosive limit can ignite from frictional heating in air-classifying mills. After blending, powder is discharged into lined fibre drums with antistatic polyethylene liners; the inner bag should be grounded before manual transfer. The apparent density after filling should be checked with a Scott volumeter, and packaging under 50% RH avoids compaction during storage. Topical sulfur powders are not sterile, but for application to abraded skin the aerobic microbial count should be controlled according to the relevant nonsterile preparation monograph. The absence of Pseudomonas aeruginosa and Staphylococcus aureus is verified by membrane filtration enrichment.

When Parenteral Exposure Is Considered for Sublimed Sulphur

True aqueous solutions of sulfur sublimatum are not achievable because solubility in water at 25 °C is below 10 mg/L. Suspension formulations intended for parenteral administration face sterilization constraints: moist heat at 121 °C for 15 min exposes sulfur to temperatures above the orthorhombic-to-monoclinic transition at approximately 95.6 °C, and the melting range of sublimed sulfur begins near 112 °C. Dry heat sterilization at 160 °C exceeds the melting point and is therefore unsuitable. Sterile filtration through 0.22 µm membranes cannot accommodate the particle size needed for a depot suspension. Gamma irradiation at doses of 25 kGy may generate reactive sulfur species and change particle surface properties, but published data for veterinary injectable sulfur is limited. There is no harmonized pharmacopoeial monograph establishing purity or sterility acceptance criteria for sulfur sublimatum as a parenteral API. Consequently, the injectable route is not a practical downstream segment unless the sulfur is chemically modified or encapsulated in a validated carrier system. Formulators considering oily vehicles should first measure free sulfur content after terminal sterilization and confirm absence of degradation products generated by the sterilization process by high-performance liquid chromatography.

Analytically, injectable-grade sulfur would require a particle number test under Ph. Eur. 2.9.19 for subvisible particles, but the method requires the active to be suspended in a vehicle with refractive index different from sulfur; method development is constrained because sulfur particles are opaque and settle rapidly. Bacterial endotoxin testing by Ph. Eur. 2.6.14 is applicable only after dissolution in a suitable organic solvent followed by aqueous dilution, which introduces recovery interference from sulfur-containing degradation products. Sterility testing by membrane filtration is not compatible with sulfur suspensions above 0.1% w/v because the filter becomes blocked and retains sulfur on the membrane. These constraints explain why the injectable route remains limited to experimental formulations and why commercial veterinary injectable products based on sulfur sublimatum are not widely marketed.

In feed mills producing medicated premixes, sulfur sublimatum requires distribution over a carrier with high surface area and low oil absorption. Corn cob meal at 60–80% w/w and calcium carbonate at 10–20% w/w provide a base for sulfur loadings of 5–15% w/w, but mixing times in ribbon blenders of 500 kg capacity should be validated by sampling at 10 positions because sulfur tends to migrate to the top of the blend during prolonged blending due to density differences. The coefficient of variation for sulfur content should be below 5% in the finished premix, as determined by validated high-temperature combustion analysis. Granulation of sulfur premix with 5% w/w mineral oil reduces dust and improves pellet mill throughput, but lipid coating above 8% w/w delays release in the gastrointestinal tract and may reduce efficacy in monogastric species.

Granule hardness measured by a tablet hardness tester on 1.0–1.4 mm sieve fractions should remain below 2 kp to allow disintegration in feed. Carryover between batches is a critical hazard; dedicated production lines or validated cleaning limits are required because sulfur dust accumulates in dead zones of bucket elevators and rotary valves. The finished premix should be packaged in antistatic bags equipped with conductive film to prevent electrostatic discharge during transport. The homogeneity testing plan should follow the principles of ISO 6497, with at least 10 sampling points per batch and a calculated coefficient of variation below 5%.

Oral Suspension Rheology and Sedimentation Control

Liquid veterinary preparations of sulfur sublimatum are suspensions rather than solutions because the API is practically insoluble in aqueous vehicles. The suspension stability depends on the particle size distribution and the continuous-phase yield stress. A dispersed phase with d50 ≤ 40 µm in a vehicle thickened with xanthan gum at 0.3–0.5% w/v achieves a sedimentation volume ratio above 0.90 after 24 h at 25 °C. Suspension viscosity is measured with a rotational viscometer at 25 °C and a shear rate of 10 s⁻¹; values below 1,500 mPa·s typically result in sedimentation zone formation, while values above 3,500 mPa·s make pourability difficult for dosing syringes.

Preservative efficacy in sweetened oral suspensions must be confirmed by Ph. Eur. 5.1.3 because sulfur can adsorb parabens onto the particle surface and reduce free preservative concentration. Suspensions for young ruminants should be buffered to pH 4.5–6.5 with citrate or phosphate buffers to avoid esophageal irritation. Homogenization at 3,000–5,000 rpm in a rotor-stator mixer prior to filling prevents floating sulfur agglomerates, but batch size must be matched to mixer tip speed because scale-up based on rotational speed alone produces different shear rates. The fill volume tolerances should follow the relevant pharmacopoeial general chapter for oral liquids. The use of propylene glycol above 20% v/v increases the solubility of hydrophobic impurities from sulfur and may alter organoleptic acceptance; published data for taste masking of sulfur in veterinary species is limited.